Press release
Gastroretentive Drug Delivery Systems Outsourcing Market Outlook Signals Expansion To $2.1 Billion Through 2030
Gastroretentive Drug Delivery Systems Outsourcing Market
Projected Market Value and Growth Drivers for Gastroretentive Drug Delivery Systems Outsourcing
The outsourcing market for gastroretentive drug delivery systems is projected to reach $2.1 billion by 2030, expanding at a compound annual growth rate (CAGR) of 6.9%. This upward trend is fueled by several factors, including the rise of complex drug molecules that require specialized delivery mechanisms, growing demand for patient-centric approaches, and an increase in outsourcing strategies among pharmaceutical companies. Moreover, innovations in gastroretentive technologies and efforts to reduce costs are contributing to this steady expansion. Noteworthy market trends include a heightened focus on outsourcing the development of advanced drug delivery solutions, greater adoption of formulations that prolong gastrointestinal retention, increased use of floating drug delivery systems, the growth of contract research partnerships, and initiatives aimed at boosting drug bioavailability.
The gastroretentive drug delivery systems outsourcing market size has grown strongly in recent years. It will grow from $1.49 billion in 2025 to $1.61 billion in 2026 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to limitations of conventional oral drug delivery, growth in cro services, need for improved drug absorption, pharmaceutical pipeline expansion, formulation technology advancements.
Download a free sample of the gastroretentive drug delivery systems outsourcing market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15813&type=smp&utm_source=Open&utm_medium=Paid&utm_campaign=Aug_PR
Key Players Steering the Gastroretentive Drug Delivery Systems Outsourcing Market
A number of prominent organizations are active in this market, shaping its development and competitive landscape. Leading companies include Pfizer Inc., Merck & Co. Inc., Sanofi S.A., AstraZeneca plc, and Novartis AG. Additionally, Evonik Industries AG, SGS SA, Lonza Group AG, Sun Pharmaceutical Industries Ltd., Catalent Inc., and AptarGroup Inc. are important contributors. Other significant participants include Cadila Pharmaceuticals, Ashland Global Holdings Inc., Lupin Limited, Torrent Pharmaceuticals Ltd., Evotec SE, Colorcon Inc., Quotient Sciences Limited, Aenova Group, Vectura Group Ltd., Coating Place Inc., Xiromed LLC, and SPI Pharma Inc., all playing vital roles in advancing gastroretentive drug delivery outsourcing.
Emerging Innovations Shaping the Future of Gastroretentive Drug Delivery Systems Outsourcing
Market leaders are focusing on creating cutting-edge products to improve drug delivery efficiency and patient experience. One notable innovation is the development of ready-to-fill (RTF) colon functional capsules, which are pre-manufactured empty capsules designed to be filled with specific drugs tailored for colon targeting. These capsules simplify formulation and accelerate the drug development timeline. For instance, in September 2024, Evonik, a Germany-based advanced drug delivery firm, introduced EUDRACAP colon functional capsules. These capsules are intended for targeted delivery to the ileo-colonic region and are the first ready-to-fill option available for sensitive active ingredients such as live biotherapeutic products (LBPs). While currently offered in technical grade, a GMP-grade product is also under development. This innovation represents a significant advancement by easing oral drug formulation and speeding up time to market.
View the full gastroretentive drug delivery systems outsourcing market report:
https://www.thebusinessresearchcompany.com/report/gastroretentive-drug-delivery-systems-outsourcing-global-market-report?utm_source=Open&utm_medium=Paid&utm_campaign=Aug_PR
Market Segmentation Overview of the Gastroretentive Drug Delivery Systems Outsourcing Industry
This report breaks down the gastroretentive drug delivery systems outsourcing market into several critical segments:
1) By Type: Floating Systems, Bioadhesive Systems, and Other Types
2) By Dosage Form: Tablets, Liquid, Microspheres, Capsules, and Other Dosage Forms
3) By Application: Gastroesophageal Reflux Disease (GERD), Neurological Disorders, and Other Applications
4) By End User: Pharmaceutical Companies, Contract Research Organizations (CROs), and Other End Users
Further subcategories include:
- Floating Systems, divided into Single Unit Systems and Multiple Unit Systems
- Bioadhesive Systems, broken down into Hydrogels and Mucoadhesive Polymers
- Other Types, which encompass Magnetically Assisted Systems, High-Density Systems, and Osmotic Systems
These classifications provide a detailed insight into the various facets and specialized areas of the gastroretentive drug delivery systems outsourcing market, highlighting its diverse applications and technology-specific developments.
What's included in our 2026 market reports:
• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gastroretentive Drug Delivery Systems Outsourcing Market Outlook Signals Expansion To $2.1 Billion Through 2030 here
News-ID: 4607467 • Views: …
More Releases from The Business Research Company
Gene Switch Market Research Reveals Path To $1.8 Billion By 2030
The gene switch market is emerging as a pivotal segment within biotechnology, promising significant advancements in how therapies are developed and controlled. With rapid innovation and growing investments, this sector is set to expand considerably, driven by new therapeutic techniques and increasing applications across personalized medicine.
Projected Growth and Market Size of the Gene Switch Industry
The gene switch market is anticipated to experience swift expansion in the coming years,…
Gaucher's Disease Market Report Examines Industry Trends, Growth Drivers And Fut …
The market for Gaucher's disease treatments is set to experience considerable growth over the coming years, driven by advancements in medical therapies and improved diagnostic methods. This sector is evolving rapidly as new technologies and treatment options improve patient outcomes and expand access to care.
Projected Expansion of the Gaucher's Disease Market by 2030
The Gaucher's disease market is anticipated to grow significantly, reaching a valuation of $2.32 billion by…
Gene Delivery Technologies Market Demonstrates Long-Term Growth Potential At 14. …
The gene delivery technologies sector is gearing up for substantial expansion over the coming years, driven by significant advancements and growing demand across medical and research fields. As innovative approaches to gene therapy develop and clinical trials multiply, this market is positioned for remarkable growth by 2030. Below, we explore the market size projections, leading industry players, emerging trends, and key segmentation insights.
Projected Market Growth and Size for Gene Delivery…
Gastrointestinal Stromal Tumor Market Report Examines Leading Companies And Grow …
The gastrointestinal stromal tumor (GIST) market is on a promising trajectory, with expectations of substantial growth over the coming years. Advancements in targeted therapies and precision medicine are playing a crucial role in shaping the future of treatment options and boosting market expansion. Let's explore the market size projections, key players, prevailing trends, and segmentation that define this evolving healthcare sector.
Projected Growth and Market Size of the Gastrointestinal Stromal Tumor…
More Releases for Gastroretentive
Emerging Gastroretentive Drug Delivery Systems Outsourcing Market Trends: Innova …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Gastroretentive Drug Delivery Systems Outsourcing Market Size Growth Forecast: What to Expect by 2025?
The market for outsourced gastroretentive drug delivery systems has seen remarkable growth in recent years. The market is projected to expand from $1.39 billion in 2024 to $1.5 billion in 2025, exhibiting a compound annual…
Rising Prevalence Of Gastrointestinal Disorders Drives Growth In Gastroretentive …
The Gastroretentive Drug Delivery Systems Outsourcing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Gastroretentive Drug Delivery Systems Outsourcing Market Size and Its Estimated Growth Rate?
The gastroretentive drug delivery systems outsourcing market has shown strong growth in recent years. It will…
Gastroretentive Drug Delivery Systems Outsourcing Market Expands as Bioavailabil …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Gastroretentive Drug Delivery Systems Outsourcing Market- (By Dosage Form (Tablets, Liquid, Microspheres, Capsule, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Gastroretentive Drug Delivery Systems Outsourcing Market is valued at US$ 1.26 Bn in 2022, and it is expected to reach US$ 2.32 Bn…
Top Factor Driving Gastroretentive Drug Delivery Systems Outsourcing Market Grow …
Which drivers are expected to have the greatest impact on the over the gastroretentive drug delivery systems outsourcing market's growth?
The increasing incidence of gastrointestinal disorders is expected to boost the growth of the gastroretentive drug delivery systems outsourcing market. Gastrointestinal disorders are on the rise due to factors like aging populations, antibiotic use, changes, and obesity. Outsourcing gastroretentive drug delivery systems allows pharmaceutical companies to address the growing demand…
Rising Prevalence Of Gastrointestinal Disorders Drives Growth In Gastroretentive …
How Will the Gastroretentive Drug Delivery Systems Outsourcing Market Grow, and What Is the Projected Market Size?
In recent times, the market size for outsourcing of gastroretentive drug delivery systems has expanded significantly. Projected growth estimates indicate an increase from $1.39 billion in 2024 to $1.5 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.3%. Several factors have contributed to this growth during the historic period, including a…
Gastroretentive Drug Delivery Systems Market Outlook 2029: Presents Market Insig …
The global gastroretentive drug delivery systems market is anticipated to grow at a CAGR of around 6.3% during the forecast period. The rising prevalence of functional gastrointestinal disorders (FGIDs), and gastric disorders majorly among the geriatric population globally is the major factor augmenting the growth of the gastroretentive drug delivery systems. The aged population is more susceptible to long-standing conditions such as dyspepsia, irritable bowel syndrome, inflammatory bowel disease (Crohn's disease and…
